文献速递生殖医学

接受促排卵宫腔内人工授精女性的子宫内膜厚度:多薄才算过薄?系统综述与Meta分析

Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis.
PubMed 文献 · Hum Reprod · 2017-01-01

该系统综述与Meta分析检索至2016年6月28日,纳入23项研究共3846例不明原因不孕接受宫腔内人工授精联合促排卵的女性,发现子宫内膜厚度与妊娠机会无证据关联;氯米芬组子宫内膜厚度显著薄于促性腺激素组。

要点

  • 未发现促排卵宫腔内人工授精周期中子宫内膜厚度与妊娠率存在关联的证据。
  • 氯米芬组子宫内膜厚度显著薄于促性腺激素组(MD -0.33,95%CI -0.64至-0.01)。
  • 因子宫内膜薄而取消宫腔内人工授精周期可能对临床诊疗产生负面影响。

核心结论

  • 未发现促排卵宫腔内人工授精过程中子宫内膜厚度与妊娠率存在关联的证据。
  • 因子宫内膜薄而取消宫腔内人工授精周期可能对临床诊疗产生负面影响。
  • 不同药物间子宫内膜厚度差异很小,可能为偶然,无法据此推断对妊娠机会的影响。

研究设计与样本

  • 系统综述与Meta分析,比较宫腔内人工授精项目中氯米芬、促性腺激素或芳香化酶抑制剂的研究。
  • 检索MEDLINE、EMBASE及PubMed非MEDLINE子集,自建库至2016年6月28日。
  • 共纳入23项研究,总计3846例女性,其中17项随机对照试验和6项队列研究。

主要发现

  • 7项研究提供子宫内膜厚度与妊娠关系的数据,妊娠组与未妊娠组子宫内膜厚度无证据差异(1525例女性,随机效应模型MD 0.51 mm,95%CI -0.05至1.07)。
  • 氯米芬组子宫内膜厚度显著薄于促性腺激素组(2项研究,MD -0.33,95%CI -0.64至-0.01)。
  • 氯米芬与来曲唑比较,子宫内膜厚度无证据差异(5项研究,随机效应模型MD -0.84,95%CI -1.97至0.28)。
  • 氯米芬联合促性腺激素组子宫内膜厚度略薄于来曲唑组(9项研究,随机效应模型MD -0.79,95%CI -1.37至-0.20)。
  • 来曲唑组子宫内膜厚度薄于促性腺激素组(2项研究,随机效应模型MD -1.31,95%CI -2.08至-0.53)。

关键数值与推荐

  • 使用固定效应模型计算均数差(MD)及95%CI,异质性I²>50%时改用随机效应模型。
  • 采用Meta回归分析评估刺激药物是否与子宫内膜厚度的估计效应存在交互作用。

临床怎么用

  • 作者认为,因子宫内膜薄而取消宫腔内人工授精周期可能对临床诊疗产生负面影响。
  • 作者指出,不同药物间子宫内膜厚度差异可能为偶然,无法据此推断对妊娠机会的影响。

局限性

  • 纳入研究的总体质量为低至中等。
  • 各比较中存在相当至较大的统计学异质性,妨碍得出确切结论。
  • 平均研究质量低,存在相当至较大的统计学异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is pre-ovulatory endometrial thickness (EMT) in women with unexplained subfertility undergoing IUI with ovarian stimulation (OS) associated with pregnancy chances? SUMMARY ANSWER: We found no evidence for an association between EMT and pregnancy chances. WHAT IS KNOWN ALREADY: It has been suggested that OS with clomiphene citrate (CC) results in a lower EMT than with gonadotrophins or aromatase inhibitors, but the clinical consequences in terms of pregnancy are unclear. STUDY DESIGN, SIZE, DURATION: We performed a systematic review and meta-analysis of studies comparing CC, gonadotrophins or aromatase inhibitors in an IUI program reporting on EMT and pregnancy rates in women with unexplained subfertility. PARTICIPANTS/MATERIALS, SETTING, METHODS: We searched MEDLINE, EMBASE and the non-MEDLINE subset of PubMed from inception to 28th June 2016 and cross-checked references of relevant articles. Outcome measures were clinical pregnancy rate and mean pre-ovulatory EMT. We calculated mean differences (MD) with 95% CIs with a fixed effect model, and in case of heterogeneity with an I2 > 50% a random effect model. We performed a meta-regression analysis to determine if stimulating drugs interacted with the estimated effect of EMT. MAIN RESULTS AND THE ROLE OF CHANCE: Our search retrieved 1563 articles of which 23 were included, totaling 3846 women. There were 17 RCTs and 6 cohort studies. The average study quality was low and there was considerable to substantial statistical heterogeneity. Seven studies provided data on EMT in relation to pregnancy. There was no evidence of a difference in EMT between women who conceived and women that did not conceive (1525 women, MDrandom: 0.51 mm, 95% CI: -0.05 to 1.07). Women treated with CC had a significantly thinner EMT than women treated with gonadotrophins (two studies, MD: -0.33, 95% CI: -0.64 to -0.01). There was no evidence of a difference in EMT when comparing CC with letrozole (five studies, MDrandom: -0.84, 95% CI: -1.97 to 0.28). The combination of CC plus gonadotrophins resulted in a slightly thinner endometrium than letrozole (nine studies, MDrandom: -0.79, 95% CI: -1.37 to -0.20). Letrozole resulted in a thinner EMT than gonadotrophins (two studies, MDrandom: -1.31, 95% CI: -2.08 to -0.53). LIMITATIONS, REASONS FOR CAUTION: The overall quality of the included studies was low to moderate. We found considerable to substantial heterogeneity in the comparisons, hampering firm conclusions. WIDER IMPLICATIONS OF THE FINDINGS: We found no evidence for an association between EMT and pregnancy rates during IUI -OS. As a consequence, canceling IUI cycles because of a thin endometrial lining may negatively affect clinical care. Although we found some evidence for very small differences in EMT when comparing various drugs, we cannot make inferences on their effect on pregnancy chances since these differences may be coincidental. STUDY FUNDING/COMPETING INTEREST(S): None. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Weiss NS, van Vliet MN, Limpens J, et al. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis. Hum Reprod. 2017. PMID: 28333207. doi:10.1093/humrep/dex035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。